On June 18, The Block reported that Nasdaq-listed healthcare company Prenetics Global announced the launch of a Bitcoin strategy. The company has completed the purchase of 187.42 Bitcoins through a CEX accomplice account at an average price of $106,712. The company stated that earlier, it had divested ACT Genomics earlier on Wednesday, which increased Prenetics' total cash, Bitcoin, and short-term assets to approximately $117 million, enabling the company to implement a comprehensive Bitcoin strategy. Prenetics also announced the appointment of former CEX Chief Operating Officer Andy Cheung to the board, bringing cryptocurrency industry experience to help guide its long-term Bitcoin strategy. In addition, CEX Strategic Plan Chief of Staff and Bitcoin Advocacy Project board member Tracy Hoyos Lopez also joined Prenetics as an advisor.
The content is for reference only, not a solicitation or offer. No investment, tax, or legal advice provided. See Disclaimer for more risks disclosure.
The US-listed healthcare company Prenetics is transforming its Bitcoin strategy and has purchased 187.42 Bitcoins.
On June 18, The Block reported that Nasdaq-listed healthcare company Prenetics Global announced the launch of a Bitcoin strategy. The company has completed the purchase of 187.42 Bitcoins through a CEX accomplice account at an average price of $106,712. The company stated that earlier, it had divested ACT Genomics earlier on Wednesday, which increased Prenetics' total cash, Bitcoin, and short-term assets to approximately $117 million, enabling the company to implement a comprehensive Bitcoin strategy. Prenetics also announced the appointment of former CEX Chief Operating Officer Andy Cheung to the board, bringing cryptocurrency industry experience to help guide its long-term Bitcoin strategy. In addition, CEX Strategic Plan Chief of Staff and Bitcoin Advocacy Project board member Tracy Hoyos Lopez also joined Prenetics as an advisor.